Guinea-Bissau’s health minister, Quinhin Nantote, said the government never authorized a Danish-led, US-backed hepatitis B study in newborns, despite reports of approval. The trial would track outcomes including mortality and neurodevelopment rather than vaccine safety or effectiveness.